https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MS.jpg

Vascular Access Devices Market Analysis, Size, Trends | Europe | 2020-2026 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: Europe
  • Pages: 934
  • Published Date: 05/11/2020
  • Type: MedSuite

By 2020, the European vascular access devices market size was valued at €1.7 billion, with around 130 million vascular access devices placed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 1.7% to reach €1.9 billion in 2026.

Throughout this medical market research, we analyzed 63 vascular access companies across Europe and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all the EU Vascular Access Devices market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Vascular Access Procedure Volumes
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Vascular Access Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Market Value and Industry Trends

Market growth is expected to be limited by pricing pressures across Europe. European healthcare facilities often trend towards lower-cost products, which forces many competitors to lower their prices. Furthermore, preferences for high cost, premium-priced versions of products, such as those with antimicrobial coatings, is still developing in many markets. As such, premiums on many of these devices are still being kept low and, therefore, there is not a significant upward force on the market from conversion to these products.

EU Vascular Access Devices Market Size by Segment, 2016-2026

On the other hand, the market is benefitting from increased conversion towards safety devices that prevent needle-stick injuries. This trend is having a particularly strong effect in the PIVC and syringe and needle markets, which represent a sizable portion of the total vascular access market in Europe. Europe-wide legislation encouraging the use of safety devices implemented in 2013 and early 2014 has been transposed in all countries included in this report.

Long-term devices, such as implantable ports, CVCs, and PICCs, are expected to be among the fastest-growing segments of the global vascular access device market. Long-term catheters are typically much more expensive than short-term devices, like PIVCs. Furthermore, there is a high degree of motivation for technological improvement in those spaces. Power-injection is a growing trend for implantable ports and PICCs, allowing for high-pressure injections, such as those required for CT scans.

Competitive Analysis

Leading Competitors in the EU Vascular Access Market

By 2020, Becton Dickinson led the European vascular access device and accessories market. Since its 2017 acquisition of C.R. Bard, Becton Dickinson has continued to be a major player in both traditional vascular access devices and accessories. With the acquisition of C.R. Bard, the company
now leads the majority of market segments covered in this report, and is the second or third leading competitor in most of the remaining markets.

B. Braun was the second-most-prominent competitor in the European vascular access market by 2020. The company managed this by being the second-leading competitor in a large host of markets, including implantable ports, port needles, CVCs, PIVCs and syringes and needles.

3M, despite only being present in the catheter securement market, was the third-largest player in the total vascular access device and accessories market. 3M derives its large revenue share from its high-volume sales of catheter dressings and securement devices, which are used with the majority of catheters placed in Europe.

REPORT REGIONAL COVERAGE

Throughout this research series, iData Research has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Switzerland
  • Austria
  • Portugal

Segments Covered

Feel free to click on any of the segments below to view detailed market segmentation.

Detailed Market Segmentation


DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS I

LIST OF FIGURES XIII
LIST OF CHARTS XLI
EXECUTIVE SUMMARY 1

EUROPEAN VASCULAR ACCESS DEVICES AND ACCESSORIES MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 14
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 19
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29

DISEASE OVERVIEW 30

2.1 BASIC ANATOMY 30
2.1.1 Human Vascular System 30
2.2 DISEASE TREATMENTS & DIAGNOSTICS 31
2.2.1 Cancer 31
2.2.2 End-Stage Renal Disease 32
2.2.3 Diabetes 34
2.3 PATIENT DEMOGRAPHICS 37
2.3.1 Cancer 37
2.3.1.1 Breast Cancer 37
2.3.1.2 Colon and Rectum 38
2.3.1.3 Kidney and Renal Pelvis 39
2.3.1.4 Leukemia 39
2.3.1.5 Liver 40
2.3.1.6 Lungs and Bronchus 40
2.3.1.7 Lymphoma 41
2.3.1.8 Oral Cavity and Pharynx 41
2.3.1.9 Ovary 42
2.3.1.10 Pancreas 42
2.3.1.11 Prostate 43
2.3.1.12 Skin 43
2.3.2 End-Stage Renal Disease 43
2.3.3 Diabetes 44

PRODUCT ASSESSMENT 47

3.1 INTRODUCTION 47
3.2 PRODUCT PORTFOLIOS 47
3.2.1 Port Needles 47
3.2.1.1 Introduction 47
3.2.1.2 Product Portfolio 48
3.2.2 Implantable Ports 49
3.2.2.1 Introduction 49
3.2.2.1.1 Implantable Port Patients 49
3.2.2.1.2 Port Implantation Procedures 49
3.2.2.1.3 Port Infusion 50
3.2.2.1.4 Port Maintenance 50
3.2.2.2 Product Portfolio 51
3.2.3 Central Venous Catheters (CVCs) 52
3.2.3.1 Introduction 52
3.2.3.1.1 CVC Procedures 52
3.2.3.1.2 CVC Kits 53
3.2.3.1.3 CVC Market Segments 53
3.2.3.2 Product Portfolio 56
3.2.4 Peripherally Inserted Venous Catheters (PIVCs) 58
3.2.4.1 Introduction 58
3.2.4.2 Product Portfolio 59
3.2.5 Peripherally Inserted Central Catheters (PICCs) 61
3.2.5.1 Introduction 61
3.2.5.2 PICC Placement 61
3.2.5.3 Product Portfolio 62
3.2.6 Midlines 64
3.2.6.1 Product Portfolio 64
3.2.7 Dialysis Catheters 65
3.2.7.1 Introduction 65
3.2.7.1.1 AV Fistulae 65
3.2.7.1.2 AV Grafts 66
3.2.7.1.3 Dialysis Catheters 66
3.2.7.2 Product Portfolio 69
3.2.8 Syringes and Needles 71
3.2.8.1 Introduction 71
3.2.8.2 Product Portfolio 73
3.2.9 Catheter Securement 76
3.2.9.1 Introduction 76
3.2.9.1.1 Catheter Stabilization Methods 76
3.2.9.2 Product Portfolio 79
3.2.10 Tip-Placement System and Accessories 81
3.2.10.1 Introduction 81
3.2.10.2 Product Portfolio 82
3.2.11 Ultrasound Vascular Access Devices and Accessories 83
3.2.11.1 Introduction 83
3.2.11.1.1 Alternates to Ultrasound Guidance 83
3.2.11.1.2 Ultrasound Guidance 84
3.2.11.1.3 Ultrasound Vessel Mapping 85
3.2.11.1.4 General Ultrasound Imaging Systems with Vascular Access Guidance Capabilities Market 85
3.2.11.2 Product Portfolio 86
3.2.12 Vein Visualization Technology 89
3.2.12.1 Product Portfolio 89
3.3 FDA RECALLS 90
3.3.1 Port Needles 90
3.3.2 Implantable Ports 90
3.3.3 Central Venous Catheters (CVCs) 91
3.3.4 Peripherally Inserted Central Catheters (PICCs) 93
3.4 CLINICAL TRIALS 94
3.4.1 Vascular Access Devices 94

EUROPEAN VASCULAR ACCESS DEVICES AND ACCESSORIES MARKET OVERVIEW 100

4.1 INTRODUCTION 100
4.2 CURRENCY EXCHANGE RATE 101
4.3 MARKET OVERVIEW 102
4.4 TREND ANALYSIS BY SEGMENT 110
4.5 DRIVERS AND LIMITERS 115
4.5.1 Market Drivers 115
4.5.2 Market Limiters 116
4.6 COMPETITIVE MARKET SHARE ANALYSIS 119
4.7 MERGERS AND ACQUISITIONS 127
4.8 COMPANY PROFILES 130
4.8.1 3M 130
4.8.2 AngioDynamics 131
4.8.3 B. Braun 132
4.8.4 Becton Dickinson 133
4.8.5 Cook Medical 135
4.8.6 FUJIFILM SonoSite 136
4.8.7 GE Healthcare 137
4.8.8 Medcomp 138
4.8.9 Medtronic 139
4.8.10 Novo Nordisk 140
4.8.11 Smiths Medical 141
4.8.12 Siemens 142
4.8.13 Teleflex Medical 143
4.9 SWOT ANALYSIS 145
4.9.1 3M 145
4.9.2 AngioDynamics 146
4.9.4 B. Braun 147
4.9.5 Becton Dickinson 148
4.9.6 Cook Medical 149
4.9.7 FUJIFILM SonoSite 150
4.9.8 GE Healthcare 151
4.9.9 Medcomp 152
4.9.10 Medtronic 153
4.9.11 Novo Nordisk 154
4.9.12 Smiths Medical 155
4.9.13 Siemens 156
4.9.14 Teleflex Medical 157

COUNTRY PROFILES 158

5.1 INTRODUCTION 158
5.1.1 Population 158
5.1.2 GDP Per Capita 158
5.1.3 Price Index 158
5.2 GERMANY 159
5.3 FRANCE 160
5.4 UNITED KINGDOM 161
5.5 ITALY 162
5.6 SPAIN 163
5.7 BENELUX 164
5.8 SCANDINAVIA 165
5.9 AUSTRIA 166
5.10 SWITZERLAND 167
5.11 PORTUGAL 168

PROCEDURE NUMBERS 169

6.1 PROCEDURES 169
6.1.1 Total Vascular Access Procedures 169
6.1.2 Implantable Port Procedures 173
6.1.3 Port Needle Procedures 176
6.1.4 CVC Procedures 179
6.1.5 PICC Procedures 182
6.1.6 PIVC Procedures 185
6.1.7 Midline Procedures 188
6.1.8 Dialysis Catheter Procedures 191

IMPLANTABLE PORT MARKET 197

7.1 INTRODUCTION 197
7.2 MARKET OVERVIEW 198
7.3 MARKET ANALYSIS AND FORECAST 203
7.3.1 Total Implantable Port Market 203
7.3.2 Total Non-Power-Injectable Implantable Port Market 211
7.3.2.1 Single-Lumen Non-Power-Injectable Implantable Port Market 222
7.3.2.2 Double-Lumen Non-Power-Injectable Implantable Port Market 229
7.3.3 Total Power-Injectable Implantable Port Market 236
7.3.3.1 Single-Lumen Power-Injectable Implantable Port Market 247
7.3.3.2 Double-Lumen Power-Injectable Implantable Port Market 254
7.4 DRIVERS AND LIMITERS 261
7.4.1 Market Drivers 261
7.4.2 Market Limiters 262
7.5 COMPETITIVE MARKET SHARE ANALYSIS 265

PORT NEEDLE MARKET 270

8.1 INTRODUCTION 270
8.2 MARKET OVERVIEW 271
8.3 MARKET ANALYSIS AND FORECAST 277
8.3.1 Total Port Needle Market 277
8.3.2 Conventional Port Needle Market 285
8.3.3 Total Safety Port Needle Market 293
8.3.3.1 Power-Injectable Safety Port Needle Market 304
8.3.3.2 Non-Power-Injectable Safety Port Needle Market 312
8.4 DRIVERS AND LIMITERS 319
8.4.1 Market Drivers 319
8.4.2 Market Limiters 320
8.5 COMPETITIVE MARKET SHARE ANALYSIS 321

CENTRAL VENOUS CATHETER MARKET 326

9.1 INTRODUCTION 326
9.2 UNIT ANALYSIS 327
9.2.1.1 Acute CVC Units Sold by Patient Type 327
9.3 MARKET OVERVIEW 328
9.4 MARKET ANALYSIS AND FORECAST 334
9.4.1 Total Central Venous Catheter Market 334
9.4.2 Total Acute Central Venous Catheter Market 342
9.4.2.1 Total Acute Central Venous Catheter Market by Device Type 342
Conventional Acute Central Venous Catheter Market 353
Antimicrobial Acute Central Venous Catheter Market 361
9.4.2.2 Total Acute Central Venous Catheter Market by Power-Injectability 369
Power-Injectable Acute Central Venous Catheter Market 375
Non-Power-Injectable Acute Central Venous Catheter Market 378
9.4.3 Chronic Central Venous Catheter Market 380
Power-Injectable Chronic Central Venous Catheter Market 391
Non-Power-Injectable Chronic Central Venous Catheter Market 393
9.5 DRIVERS AND LIMITERS 395
9.5.1 Market Drivers 395
9.5.2 Market Limiters 396
9.6 COMPETITIVE MARKET SHARE ANALYSIS 398

PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 406

10.1 INTRODUCTION 406
10.2 MARKET OVERVIEW 407
10.2.1 Total Peripherally Inserted Central Catheter Market by Lumen Number 407
10.2.2 Total Peripherally Inserted Central Catheter Market by Power-Injectability 412
10.2.3 Total Peripherally Inserted Central Catheter Market by Tip-Placement Type 418
10.3 MARKET ANALYSIS AND FORECAST 423
10.3.1 Total Peripherally Inserted Central Catheter Market 423
10.3.2 Total Peripherally Inserted Central Catheter Market by Lumen Number 431
10.3.2.1 Single-Lumen Peripherally Inserted Central Catheter Market 431
10.3.2.2 Double-Lumen Peripherally Inserted Central Catheter Market 439
10.3.2.3 Triple-Lumen Peripherally Inserted Central Catheter Market 446
10.3.3 Total Peripherally Inserted Central Catheter Market by Power-Injectability 453
10.3.3.1 Non-Power-Injectable Peripherally Inserted Central Catheter Market 453
10.3.3.2 Total Power-Injectable Peripherally Inserted Central Catheter Market 461
10.3.3.2.1 Advanced Materials Power-Injectable Peripherally Inserted Central Catheter Market 472
10.3.3.2.2 Conventional Power-Injectable Peripherally Inserted Central Catheter Market 479
10.3.4 Total Peripherally Inserted Central Catheter Market by Tip-Placement Type 486
10.3.4.1 Tip-Placement Peripherally Inserted Central Catheter Kit Market 486
10.3.4.2 Basic Peripherally Inserted Central Catheter Kit Market 493
10.4 DRIVERS AND LIMITERS 500
10.4.1 Market Drivers 500
10.4.2 Market Limiters 501
10.5 COMPETITIVE MARKET SHARE ANALYSIS 503

PERIPHERAL INTRAVENOUS CATHETER MARKET 508

11.1 INTRODUCTION 508
11.2 MARKET OVERVIEW 510
11.3 MARKET ANALYSIS AND FORECAST 516
11.3.1 Total Peripheral Intravenous Catheter Market 516
11.3.2 Conventional Peripheral Intravenous Catheter Market 524
11.3.3 Total Safety Peripheral Intravenous Catheter Market 532
11.3.3.1 Blood Control Safety Peripheral Intravenous Catheter Market 543
11.3.3.2 Total Non-Blood Control Safety Peripheral Intravenous Catheter Market by Segment 551
11.3.3.2.1 Active Non-Blood Contro Safetyl Peripheral Intravenous Catheter Market 562
11.3.3.2.2 Passive Non-Blood Control Safety Peripheral Intravenous Catheter Market 569
11.4 DRIVERS AND LIMITERS 576
11.4.1 Market Drivers 576

For a Full Table of Contents, please contact iData.
The Vascular Access Devices Market Report Suite | Europe | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • 3M
  • Access Scientific
  • AngioDynamics
  • Applied Medical Technology
  • Argon Medical
  • Artsana
  • B. Braun
  • Baxter International
  • Becton Dickinson
  • Bionic
  • C. R. Bard
  • Cardinal Health
  • Centurion Medical
  • Codan
  • Cook Medical
  • Covidien
  • Deltamed
  • DeRoyal
  • Districlass Medical
  • Edwards Lifesciences
  • Fannin
  • Fresenius
  • GlucoRx
  • Greiner Bio-One
  • HEKA Healthcare
  • Interrad Medical
  • Investindustrial
  • Johnson & Johnson
  • Joline
  • Kimal
  • M.C. Johnson
  • Medcomp
  • Medikit
  • Medline Industries
  • Medtronic
  • Neo Medical
  • Nipro Medical
  • Nostix, LLC
  • Nova Medical
  • Novico
  • Novo Nordisk
  • Owen Mumford
  • Pentaferte
  • PFM Medical
  • Rays
  • Roche
  • Romedex
  • Safety Syringes Inc.
  • Sentra Medical
  • SFM
  • Smiths Medical
  • Smith & Nephew
  • Sonosite, Inc.
  • Teleflex
  • Terumo
  • TIDI Products
  • Troge
  • Vascular Pathways, Inc.
  • VigMed
  • V-Tech
  • Vygon
  • Ypsomed

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology